RU2006127134A - Способ лечения заболеваний - Google Patents

Способ лечения заболеваний Download PDF

Info

Publication number
RU2006127134A
RU2006127134A RU2006127134/14A RU2006127134A RU2006127134A RU 2006127134 A RU2006127134 A RU 2006127134A RU 2006127134/14 A RU2006127134/14 A RU 2006127134/14A RU 2006127134 A RU2006127134 A RU 2006127134A RU 2006127134 A RU2006127134 A RU 2006127134A
Authority
RU
Russia
Prior art keywords
patient
treating diseases
fragmented dna
dna
amount
Prior art date
Application number
RU2006127134/14A
Other languages
English (en)
Other versions
RU2322264C1 (ru
Inventor
Михаил Аркадьевич Шурдов (RU)
Михаил Аркадьевич Шурдов
Сергей Станиславович Богачев (RU)
Сергей Станиславович Богачев
Леонид Анатольевич Якубов (RU)
Леонид Анатольевич ЯКУБОВ
Владимир Алексеевич Рогачев (RU)
Владимир Алексеевич Рогачев
Валерий Петрович Николин (RU)
Валерий Петрович Николин
Нелли Александровна Попова (RU)
Нелли Александровна Попова
Анастаси Сергеевна Лихачева (RU)
Анастасия Сергеевна Лихачева
Тамара Егоровна Себелева (RU)
Тамара Егоровна Себелева
Александр Геннадиевич Шилов (RU)
Александр Геннадиевич Шилов
Наталь Сергеевна Жданова (RU)
Наталья Сергеевна Жданова
Людмила Васильевна Мечетина (RU)
Людмила Васильевна Мечетина
Оксана В чеславовна Врацких (RU)
Оксана Вячеславовна Врацких
Сергей Николаевич Серегин (RU)
Сергей Николаевич Серегин
Елена Рэмовна Черных (RU)
Елена Рэмовна Черных
Евгений Львович Гельфгат (RU)
Евгений Львович Гельфгат
Original Assignee
Михаил Аркадьевич Шурдов (RU)
Михаил Аркадьевич Шурдов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Михаил Аркадьевич Шурдов (RU), Михаил Аркадьевич Шурдов filed Critical Михаил Аркадьевич Шурдов (RU)
Priority to RU2006127134/14A priority Critical patent/RU2322264C1/ru
Priority to PCT/RU2007/000007 priority patent/WO2008013473A1/ru
Priority to CN2007800283047A priority patent/CN101495157B/zh
Publication of RU2006127134A publication Critical patent/RU2006127134A/ru
Application granted granted Critical
Publication of RU2322264C1 publication Critical patent/RU2322264C1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (1)

  1. Способ лечения заболеваний, основанный на введении в организм пациента фрагментированной ДНК, отличающийся тем, что фрагментированная ДНК является аллогенной и состоит из фрагментов, длина которых соответствует 1-10 нуклеосомным единицам, составляющих полный геном пациента в ассоциации с белками ядерного матрикса, при этом количество фрагментированной ДНК принимают равным или превышающим количество собственно ДНК плазмы крови и тканевых жидкостей пациента, но не более 1500 нг/мл.
RU2006127134/14A 2006-07-27 2006-07-27 Способ лечения заболеваний RU2322264C1 (ru)

Priority Applications (3)

Application Number Priority Date Filing Date Title
RU2006127134/14A RU2322264C1 (ru) 2006-07-27 2006-07-27 Способ лечения заболеваний
PCT/RU2007/000007 WO2008013473A1 (fr) 2006-07-27 2007-01-11 Procédé de traitement de maladies
CN2007800283047A CN101495157B (zh) 2006-07-27 2007-01-11 疾病治疗方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2006127134/14A RU2322264C1 (ru) 2006-07-27 2006-07-27 Способ лечения заболеваний

Publications (2)

Publication Number Publication Date
RU2006127134A true RU2006127134A (ru) 2008-02-10
RU2322264C1 RU2322264C1 (ru) 2008-04-20

Family

ID=38981715

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006127134/14A RU2322264C1 (ru) 2006-07-27 2006-07-27 Способ лечения заболеваний

Country Status (3)

Country Link
CN (1) CN101495157B (ru)
RU (1) RU2322264C1 (ru)
WO (1) WO2008013473A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014013082B1 (pt) * 2011-12-07 2021-02-02 Singapore Volition Pte Limited uso de um aduto nucleossomo-proteína e métodos para detectar a presença de um aduto nucleossomo-proteína

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402642D0 (sv) * 1994-08-05 1994-08-05 Maria Anvret Gene Therapy
RU2234323C1 (ru) * 2003-05-27 2004-08-20 Шурдов Михаил Аркадьевич Препарат, обладающий противоопухолевым, антитоксическим и радиопротекторным действием

Also Published As

Publication number Publication date
CN101495157B (zh) 2013-02-13
WO2008013473A1 (fr) 2008-01-31
CN101495157A (zh) 2009-07-29
RU2322264C1 (ru) 2008-04-20

Similar Documents

Publication Publication Date Title
BRPI0507960A (pt) métodos terapêuticos empregando precursores de óxido nìtrico
BRPI0511479A (pt) molécula de ligação tendo atividade neutralizadora do vìrus da raiva, variante funcional de uma molécula de ligação, imunoconjugado, molécula de ácido nucléico, vetor, hospedeiro, método para produzir uma molécula de ligação ou uma variante funcional, composição farmacêutica, uso de uma molécula de ligação, uma variante funcional, um imunoconjugado como, ou uma composição, kit, método para identificar uma molécula de ligação ou uma molécula de ácido nucléico, e, coleção de moléculas de ligação humanas na superfìcie de pacotes genéticos replicáveis
WO2008052770A3 (en) (base-)modified rna for increasing the expression of a protein
AR032743A1 (es) Composiciones y metodos para la terapia y el diagnostico de cancer de pulmon
WO2005034843A3 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
EA200601121A1 (ru) Мутеины фактора роста фибробластов 21
UA99094C2 (ru) Способ лечения пациента с системной красной волчанкой
TR201903587T4 (tr) Telomeraz aktivitesinin artırılması için bileşimler.
WO2009106819A3 (en) Biological materials and uses thereof
WO2008093165A3 (en) The use of pgil ohgosaccharyltransferase for o-glycosylating proteins
WO2012116229A3 (en) Compositions and methods for personal tumor profiling treatment
WO2003029429A3 (en) Traversal of nucleic acid molecules through a fluid space and expression in repair cells
CY1111353T1 (el) Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης
EA201690004A1 (ru) Антитела против lamp1 и конъюгаты антитела и лекарственного средства, а также их применение
WO2016201365A3 (en) Methods for treating cancers
WO2005047469A3 (en) PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
WO2003039591A3 (de) Allogene vakzine enthaltend eine ein costimulatorisches polypeptid exprimierende tumorzelle
RU2006127134A (ru) Способ лечения заболеваний
WO2010036031A3 (en) Pauf-specific human monoclonal antibody, pharmaceutical composition for treating cancer comprising the same and method for detecting cancer using the same
AR029540A1 (es) COMPOSICIONES Y METODOS PARA EL DIAGNoSTICO Y LA TERAPIA DE CA NCER DE PULMoN
RU2006100561A (ru) Способ лечения онкологических забелеваний
WO2005110460A3 (en) Diagnosis and treatment methods related to aging, especially in muscle (14.1)
AR029547A1 (es) Composiciones y metodos para la terapia y el diagnostico de cancer de pulmon
Asilian et al. Scalp Myiasis Associated with Advanced basal cell carcinoma
CN106821981A (zh) 一种红外光增加激活性RNA（RNAa）序列进入皮肤并产生生物活性的给药方法

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20141006

MM4A The patent is invalid due to non-payment of fees

Effective date: 20150728

NF4A Reinstatement of patent

Effective date: 20170208

MM4A The patent is invalid due to non-payment of fees

Effective date: 20200728